These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32464496)

  • 21. The genetic landscape of COVID-19: A South Asian perspective.
    Thomas V; Audsley J; Kapoor N
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S38-S43. PubMed ID: 32515376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory health in athletes: facing the COVID-19 challenge.
    Hull JH; Loosemore M; Schwellnus M
    Lancet Respir Med; 2020 Jun; 8(6):557-558. PubMed ID: 32277869
    [No Abstract]   [Full Text] [Related]  

  • 23. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.
    Wu Y; Guo C; Tang L; Hong Z; Zhou J; Dong X; Yin H; Xiao Q; Tang Y; Qu X; Kuang L; Fang X; Mishra N; Lu J; Shan H; Jiang G; Huang X
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):434-435. PubMed ID: 32199469
    [No Abstract]   [Full Text] [Related]  

  • 24. 2019 Novel Coronavirus Is Undergoing Active Recombination.
    Yi H
    Clin Infect Dis; 2020 Jul; 71(15):884-887. PubMed ID: 32130405
    [No Abstract]   [Full Text] [Related]  

  • 25. Genomic and phylogenetic characterisation of an imported case of SARS-CoV-2 in Amazonas State, Brazil.
    Nascimento VAD; Corado ALG; Nascimento FOD; Costa ÁKAD; Duarte DCG; Luz SLB; Gonçalves LMF; Jesus MS; Costa CFD; Delatorre E; Naveca FG
    Mem Inst Oswaldo Cruz; 2020; 115():e200310. PubMed ID: 32997001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. China coronavirus: labs worldwide scramble to analyse live samples.
    Callaway E
    Nature; 2020 Feb; 578(7793):16. PubMed ID: 32020116
    [No Abstract]   [Full Text] [Related]  

  • 27. Genomic Epidemiology and its importance in the study of the COVID-19 pandemic.
    Rodriguez-Morales AJ; Balbin-Ramon GJ; Rabaan AA; Sah R; Dhama K; Paniz-Mondolfi A; Pagliano P; Esposito S
    Infez Med; 2020 Ahead of print Jun 1; 28(2):139-142. PubMed ID: 32275255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host Immune Response Driving SARS-CoV-2 Evolution.
    Wang R; Hozumi Y; Zheng YH; Yin C; Wei GW
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32992592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates.
    Addetia A; Xie H; Roychoudhury P; Shrestha L; Loprieno M; Huang ML; Jerome KR; Greninger AL
    J Clin Virol; 2020 Aug; 129():104523. PubMed ID: 32623351
    [No Abstract]   [Full Text] [Related]  

  • 30. Call for Papers: The Pathophysiology of COVID-19 and SARS-CoV-2 Infection.
    Morty RE; Ziebuhr J
    Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L1016-L1019. PubMed ID: 32266822
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression.
    Bohn MK; Hall A; Sepiashvili L; Jung B; Steele S; Adeli K
    Physiology (Bethesda); 2020 Sep; 35(5):288-301. PubMed ID: 32783610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bolstering Africa's coronavirus detection efforts.
    Tsanni A
    Nature; 2020 Jun; 582(7810):140. PubMed ID: 32494076
    [No Abstract]   [Full Text] [Related]  

  • 33. Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19.
    Xiao F; Sun J; Xu Y; Li F; Huang X; Li H; Zhao J; Huang J; Zhao J
    Emerg Infect Dis; 2020 Aug; 26(8):1920-1922. PubMed ID: 32421494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. China's successful control of COVID-19.
    Burki T
    Lancet Infect Dis; 2020 Nov; 20(11):1240-1241. PubMed ID: 33038941
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of SARS-CoV-2 Isolated from Asymptomatic Carriers in Tokyo.
    Nagashima M; Kumagai R; Yoshida I; Kawakami M; Nagano M; Asakura H; Kaku E; Kitamura Y; Hasegawa M; Hayashi Y; Chiba T; Sadamasu K; Yoshimura K
    Jpn J Infect Dis; 2020 Jul; 73(4):320-322. PubMed ID: 32350227
    [No Abstract]   [Full Text] [Related]  

  • 37. Viral load of SARS-CoV-2 in clinical samples.
    Pan Y; Zhang D; Yang P; Poon LLM; Wang Q
    Lancet Infect Dis; 2020 Apr; 20(4):411-412. PubMed ID: 32105638
    [No Abstract]   [Full Text] [Related]  

  • 38. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options.
    Khan S; Siddique R; Shereen MA; Ali A; Liu J; Bai Q; Bashir N; Xue M
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32161092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 Research in Brief: December, 2019 to June, 2020.
    Carvalho T
    Nat Med; 2020 Aug; 26(8):1152-1153. PubMed ID: 32778824
    [No Abstract]   [Full Text] [Related]  

  • 40. COVID-19 in a tertiary hospital from Romania: Epidemiology, preparedness and clinical challenges.
    Popescu CP; Marin A; Melinte V; Gherlan GS; Banicioiu FC; Dogaru A; Smadu S; Veja AM; Nedu E; Stanciu D; Voinescu B; Simion V; Toderan A; Dascalu A; Oprisan C; Tardei G; Nica M; Ceausu E; Ruta SM; Florescu SA
    Travel Med Infect Dis; 2020; 35():101662. PubMed ID: 32283216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.